News: Abbott Laboratories (ABT)

ABT on New York Consolidated

43.01USD
23 Jul 2014
Price Change (% chg)

$-0.08 (-0.17%)
Prev Close
$43.09
Open
$43.24
Day's High
$43.27
Day's Low
$42.87
Volume
3,600,402
Avg. Vol
5,568,515
52-wk High
$43.27
52-wk Low
$32.70

Search Stocks
Select another date:

Wed, Jul 16 2014

Photo

Abbott beats profit estimate, infant formulas rebound

- Abbott Laboratories Inc reported better-than-expected quarterly earnings on Wednesday as demand for its recently-recalled infant formulas began to recover and profit margins improved for other business segments.

BRIEF-Abbott CEO says growth for nutritional products, pharmaceuticals "getting back on track"

July 16 - Abbott Laboratories : * CEO, in conference call, says growth for nutritional products, pharmaceuticals

Sanofi held talks with Abbott, Mylan about mature drugs: document

PARIS - Sanofi has held talks with Abbott Laboratories , Mylan and private equity firms over the possible sale of a 6.3 billion euro ($8.5 billion) portfolio of mature drugs, according to an internal document seen by Reuters.

UPDATE 1-Sanofi held talks with Abbott, Mylan about mature drugs -document

* Portfolio has sales of 2.1 bln eur, enterprise value 6.3 bln eur

Sanofi held talks with Abbott, Mylan on mature drugs -document

PARIS, July 16 - Sanofi has held talks with Abbott Laboratories, Mylan and private equity firms over the possible sale of a 6.3 billion euro ($8.5 billion) portfolio of mature drugs, according to an internal document seen by Reuters.

Mylan to buy Abbott generics, cut taxes, in $5.3 billion deal

- Generic drugmaker Mylan Inc said on Monday it would buy Abbott Laboratories' branded specialty and generics business in developed markets outside the United States in a $5.3 billion deal that will bolster its product line and also cut its tax bill.

Abbott CEO says interested in acquiring more medical devices

- Abbott Laboratories <ABT.N) said on Monday it is interested in bolstering its line of medical devices, but it was becoming increasingly difficult to find appropriate and affordable products.

UPDATE 2-Mylan to buy Abbott generics, cut taxes, in $5.3 bln deal

(Adds analyst comments, details of deal, company background, stock prices)

Abbott CEO says interested in acquiring more medical devices

July 14 - Abbott Laboratories <ABT.N) said on Monday it is interested in bolstering its line of medical devices, but it was becoming increasingly difficult to find appropriate and affordable products.

UPDATE 1-India caps price of 108 more medicines; drugmakers to take hit

* Move aimed towards making drugs more affordable in India

Select another date:
Search Stocks